Product Description
The Tumor Test Marker series YRA385 to YRA391 is crafted to cater to the needs of modern laboratories seeking precision in cancer diagnosis. These innovative markers excel in detecting critical tumor markers through Chemiluminescent Immunoassay (CLIA), offering reliable results that are indispensable for early cancer detection and monitoring. Each model in the series is designed to test specific parameters, such as Alpha-fetoprotein (AFP), Carcinoembryonic Antigen (CEA), and various CA markers.
Built on the Alkaline Phosphatase (AP) platform, these markers ensure high sensitivity and accurate readings. The models are designed for convenient storage at temperatures ranging from 2-8°C, ensuring stability and longevity. Available in configurations of 24T, 50T, or 100T per box, they provide flexibility depending on the laboratory’s volume and needs. With CE, ISO13485, and FSC certifications, these markers meet rigorous international standards, guaranteeing exceptional quality and reliability in their performance.
| Model | YRA385 | YRA386 | YRA387 | YRA388 | YRA389 | YRA390 | YRA391 |
|---|---|---|---|---|---|---|---|
| Tested Parameter | AFP | CEA | CA125 | CA15-3 | CA19-9 | f-PSA | t-PSA |
| Analysis Mode | CLIA | ||||||
| Package Specification | 50T/BOX, 100T/BOX, 24T/BOX | ||||||
| Platform | AP(Alkaline Phosphatase) | ||||||
| Storage | 2-8°C | ||||||
| Calibration | 2/6 Points | ||||||
| Certification | CE, ISO13485, FSC | ||||||
Market Price
The market for tumor test markers is highly competitive, with pricing typically influenced by the complexity and accuracy of the test kits. The YRA385 to YRA391 series offers a range of prices, staying competitive while ensuring delivery of advanced diagnostic capabilities. While exact prices can vary due to market fluctuations and specific laboratory needs, generally, these models are priced between $500 to $1500 per box depending on the number of tests and specific parameters they can assess.
For precise pricing and the best deals, customers are encouraged to request a quotation directly through our Kalstein Plus platform to receive tailored offers that meet their laboratory’s specific requirements.
Frequently Asked Questions
What is the shelf life of these tumor test markers?
The markers are designed to maintain their reliability and accuracy when stored appropriately at temperatures between 2-8°C. Shelf life specifics are available in the product manual, generally guaranteeing optimal performance over a significant period.
How do I ensure the accuracy of test results?
To guarantee accurate results, it is recommended to follow our detailed calibration protocol, which offers 2 or 6 points calibration. Consistent calibration is vital for maintaining the integrity of the assay results.
Are there any special storage requirements?
The storage temperature should be maintained between 2-8°C to ensure consistency in test results. It is crucial to protect the boxes from excessive moisture and direct sunlight.
Advantages and Disadvantages
Advantages: The YRA series excels in providing a highly sensitive, reliable, and reproducible method for tumor marker detection. The CLIA platform ensures rapid processing and analysis, beneficial for high-throughput laboratory settings. They also have comprehensive international certifications, ensuring worldwide applicability and recognition.
Disadvantages: One potential downside could be the requirement of specialized equipment for CLIA, which might not be available in all laboratory settings. Additionally, to achieve precise results, consistent calibration and training are essential, potentially increasing operational efforts in certain circumstances.
Product Usage in the Field
The YRA385 to YRA391 markers are predominantly used in clinical diagnostics for the early detection and monitoring of various cancers. In practice, these tests are incorporated into routine laboratory workflows, providing critical data that supports clinical decisions. The quick turnaround time and high specificity of results make these tests integral in oncology departments, where timely and accurate data is of utmost importance.
As these markers support a range of tumor types, laboratories often deploy multiple models from the series, enhancing their diagnostic capabilities across different patient profiles. This adaptability is crucial in tailoring personalized treatment and monitoring plans for cancer patients.
Recommendations
To maximize the efficiency and reliability of the YRA tumor test markers, it is advised to regularly review and update your laboratory’s calibration procedures. Continued staff training on the use of CLIA and AP platforms will help minimize errors, ensuring the accuracy of diagnostic results. Additionally, facilities should establish robust inventory management systems to ensure reagents and test kits are readily available and stored under optimal conditions.
Incorporating these innovative tumor markers into your diagnostic toolkit not only improves your lab’s service offering but also enhances the quality of patient care, contributing significantly to the medical community. For labs looking to upgrade or expand their diagnostic capabilities, consider these state-of-the-art markers by securing your quota through Kalstein Plus for the most competitive pricing and exceptional customer support.
If you are looking for a fusion of innovation and quality, you have come to the right place. At Kalstein, we offer you the luxury of exploring our exclusive catalog of laboratory equipment. We manufacture each device with a level of excellence. Our intuitive and agile online purchase channels are designed for your convenience, ensuring the most friendly prices. Don’t hesitate any longer. We bring science to life; it’s time to become part of our community. https://kalstein.net/en/product/tumor-test-marker-yra385-yra391/.
